Visualizing Angiogenesis A CREST Initiative Elise A. Pellmann – Marquette University Daniel Sem, Ph.D. – Concordia University Wisconsin David Goodsell, Ph.D. – Scripps Research Institute
2. Movie 1. Cellular landscape
2 x 10 7 magnification Show: MAPK and receptor tyrosine kinase signaling VEGF, plurality of biochemical cascades angiogenesis cell permeability
Knowledge needed for landscape pathway: which proteins? size, domain arrangement/shape, assembly, modifications, interactions/function
Pathway: KEGG
Pathway
Proteins (i)
Proteins (ii)
Sketches
Final version
2. Movie PyMOL, 3D Show: drug binding to DUSP-5
DUSP-5 ERK-2 phosphatase: P-T183, P-Y185 C-terminal phosphatase domain N-terminal ERK-binding domain linker region Ser to Pro mutation (hemangiomas)
DUSP-5 model C N catalytic domain ERK-binding domain + + – – C: PDB 2G6Z N: Homology model, NMR Linker: hand- drawn Domain orientation: good guess?
DUSP-5 model C N catalytic domain ERK-binding domain + + – – 1.ERK binding 2.catalytic domain “clamps” down 3.phosphates removed from ERK Drug impedes catalytic action, may also prevent ERK binding if DUSP-5 clamps down on drug
Daniel Sem, Terrence Neumann, Prachi Pradeep David Goodsell Margaret Franzen, MSOE CREST grant Movie viewing Thank you